top of page

Mwandishi:

ULY CLINIC

Mhariri:

ULY CLINIC

Imeboreshwa:

2 Machi 2026, 02:55:12

Adenomatoid tumors (Adenoameloblastoma)
Adenomatoid tumors (Adenoameloblastoma)

Adenomatoid tumors (Adenoameloblastoma)

Adenomatoid odontogenic tumor (AOT), historically referred to as adenoameloblastoma, is a rare benign odontogenic epithelial tumor characterized by slow growth, limited aggressiveness, and an excellent prognosis.


It represents approximately 2–7% of all odontogenic tumors and predominantly affects young individuals, especially females during the second decade of life.

Key epidemiological characteristics:

  • Female predominance (female:male ≈ 2:1)

  • Most patients aged 10–25 years

  • Two thirds occur in the anterior maxilla

  • One third occur in the anterior mandible

  • Rarely occurs posterior to premolar region


Approximately two thirds of cases are associated with an impacted tooth, most commonly the maxillary canine (cuspid).

Clinically, patients usually present with:

  • Mild painless swelling

  • Delayed tooth eruption

  • Clinically missing permanent tooth

Because of its benign behavior and encapsulation, AOT is sometimes called a “two-thirds tumor” due to its characteristic distribution.


Pathophysiology

Adenomatoid odontogenic tumor originates from odontogenic epithelium, likely derived from:

  • Reduced enamel epithelium

  • Dental lamina remnants

  • Enamel organ epithelium


Tumor Development Mechanism

  • Proliferation of odontogenic epithelial cells

  • Formation of duct-like or gland-like structures

  • Deposition of calcified material within tumor matrix

Despite gland-like microscopic appearance, AOT does not arise from glandular tissue.


Biological Behavior

  • Well encapsulated lesion

  • Non-invasive growth

  • Minimal bone destruction

  • Rare recurrence

Histologically, tumor cells arrange in:

  • Rosette patterns

  • Duct-like structures

  • Whorled epithelial formations

Calcified deposits represent enamel matrix–like material.


Signs and Symptoms

AOT commonly progresses silently.


Common Clinical Features

  • Slow painless jaw swelling

  • Facial asymmetry (mild)

  • Missing or unerupted tooth

  • Delayed tooth eruption

  • Firm intraoral swelling


Dental Findings

  • Tooth displacement

  • Minimal root resorption

  • Expansion of cortical bone


Advanced or Large Lesions

  • Occlusal disturbance

  • Jaw expansion

  • Cosmetic deformity

Pain and infection are uncommon.


Diagnostic Criteria

Diagnosis requires correlation of clinical, radiographic, and histological findings.


Clinical Criteria

  • Young patient (usually adolescent)

  • Anterior jaw involvement

  • Association with impacted tooth

  • Slow asymptomatic enlargement


Radiographic Criteria

Typical radiographic appearance includes:

  • Well-defined unilocular radiolucency

  • Frequently surrounding crown and part of root

  • Lesion attaches apically beyond cemento-enamel junction

  • Presence of fine radiopaque flecks (“snowflake calcifications”)

Important distinguishing feature:Attachment extends further along the root than dentigerous cyst.


Histopathological Criteria (Definitive)

  • Spindle-shaped epithelial cells

  • Duct-like structures lined by columnar cells

  • Eosinophilic material deposition

  • Calcifications within lesion

  • Thick fibrous capsule


Investigations


1. Clinical Examination

  • Assessment of swelling

  • Tooth eruption status

  • Occlusion evaluation


2. Radiological Investigations

Panoramic Radiograph (OPG)

  • First-line investigation

  • Shows relationship to impacted tooth

Periapical Radiograph

  • Detects internal calcifications

Computed Tomography (CT Scan)

  • Determines lesion size

  • Cortical bone involvement

  • Surgical planning

Cone Beam CT (CBCT)

  • Preferred dental imaging modality where available


3. Histopathological Examination

Mandatory to confirm diagnosis and differentiate from:

  • Dentigerous cyst

  • Ameloblastoma

  • Calcifying odontogenic cyst

  • Odontogenic keratocyst

  • Unicystic ameloblastoma


Treatment

AOT demonstrates excellent response to conservative surgery.


Non-Pharmacological Treatment


Surgical Enucleation

Treatment of choice.

Procedure includes:

  • Complete enucleation

  • Removal of associated impacted tooth if necessary

  • Curettage of surrounding bone


Characteristics favoring cure:

  • Tumor encapsulation

  • Lack of infiltration

  • Well-demarcated margins

Recurrence is extremely rare.


Postoperative Management

  • Regular follow-up radiographs

  • Monitoring bone regeneration

  • Occlusal rehabilitation if tooth loss occurs

Bone healing typically occurs spontaneously.


Pharmacological Management

No tumor-specific pharmacological therapy required.

Supportive medications include:

  • Analgesics for postoperative pain

  • Antibiotics when surgical infection risk exists

  • Anti-inflammatory medications

Radiotherapy and chemotherapy are not indicated.


Prevention

There is no known primary prevention since AOT arises from developmental odontogenic tissues.

Preventive strategies include:

  • Routine dental examination in adolescents

  • Early radiographic evaluation of unerupted teeth

  • Monitoring delayed eruption of canines

  • Early referral to dental specialists

School oral health screening programs improve early detection.


Prognosis

  • Excellent prognosis

  • Near 100% cure rate after enucleation

  • Recurrence almost unknown

  • Minimal functional impairment

Long-term outcome is highly favorable.


Clinical Importance for Mid-Level Healthcare Providers

Healthcare providers should:

  • Investigate missing permanent teeth radiographically

  • Suspect odontogenic tumor in painless anterior swelling

  • Avoid repeated extraction attempts without imaging

  • Refer early to oral and maxillofacial surgery services

  • Educate patients on follow-up importance


References

  1. Neville BW, Damm DD, Allen CM, Chi AC. Oral and Maxillofacial Pathology. 4th ed. St Louis: Elsevier; 2016.

  2. Regezi JA, Sciubba JJ, Jordan RCK. Oral Pathology: Clinical Pathologic Correlations. 7th ed. Philadelphia: Elsevier; 2017.

  3. WHO Classification of Tumours Editorial Board. Head and Neck Tumours. 5th ed. Lyon: IARC; 2022.

  4. Philipsen HP, Reichart PA. Adenomatoid odontogenic tumour: facts and figures. Oral Oncol. 1999;35(2):125–131.

  5. Marx RE, Stern D. Oral and Maxillofacial Pathology: A Rationale for Diagnosis and Treatment. 2nd ed. Quintessence; 2012.

  6. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Head and Neck Tumours. Lyon: IARC; 2017.

  7. Simon ENM, Merkx MAW, Vuhahula E, Ngassapa D, Stoelinga PJW. Odontogenic tumors in Tanzania: clinicopathological study. Int J Oral Maxillofac Surg. 2005;34(6):558–562.

  8. Ministry of Health Tanzania. Standard Treatment Guidelines and National Essential Medicines List. 2021 Edition. Dodoma: Ministry of Health; 2021.

  9. Pogrel MA. Odontogenic tumors. Oral Maxillofac Surg Clin North Am. 2013;25(1):1–12.

  10. Kramer IRH, Pindborg JJ, Shear M. Histological Typing of Odontogenic Tumours. Geneva: World Health Organization; 1992.


Imeandikwa:

4 Novemba 2020, 10:23:57

bottom of page